Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Observational, Retrospective-prospective Study Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

NCT06588205 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT06588205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06588205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Observational, Retrospective-prospective Study Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Observational
Overall status
Recruiting
Start date
May 5, 2025
Completion date
December 31, 2027
Enrollment
200 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma, high grade b-cell lymphoma with myc and bcl2 or bcl6 rearrangements, high-grade b-cell lymphoma